iShares Nasdaq Biotechnology Index Fund (IBB) Getting Positive Press Coverage, Report Finds

Press coverage about iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) has trended positive on Thursday, Accern Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. iShares Nasdaq Biotechnology Index Fund earned a news sentiment score of 0.31 on Accern’s scale. Accern also assigned media headlines about the financial services provider an impact score of 45.8410355061324 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the media stories that may have effected Accern’s analysis:

Shares of iShares Nasdaq Biotechnology Index Fund (NASDAQ IBB) traded up $1.47 on Thursday, reaching $104.05. 2,132,168 shares of the company were exchanged, compared to its average volume of 3,288,204. iShares Nasdaq Biotechnology Index Fund has a 12-month low of $87.24 and a 12-month high of $114.17.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3080575/ishares-nasdaq-biotechnology-index-fund-ibb-getting-positive-press-coverage-report-finds.html.

iShares Nasdaq Biotechnology Index Fund Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Insider Buying and Selling by Quarter for iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.